Table I.
National Department of Health (2008) | Clinical Guidelines (2010) | National Department of Health (2013) | |
---|---|---|---|
Gestation at initiation | 28 weeks | 14 weeks | Any |
Regimen during pregnancy | AZT monotherapy | AZT monotherapy | Fixed Dose Combination(FDC) – FTC/TDF/EFV |
Regimen during labor | sd NVP at onset of labor Continue with AZT 3hrly until delivery | sd NVP at onset of labor Continue with AZT 3hrly until delivery | Continue FTC/TDF/EFV |
Post delivery | Stop all ARV's | Stat dose of Truvada (TDF and FTC) | Continue FTC/TDF/EFV |
Postpartum period | No continuation during postpartum period | No continuation during postpartum period | Continue FDC for one week after cessation of breastfeeding |
Infant regimen | sd NVP and AZT(for 7 or 28 days*) | NVP for 6 weeks or for duration of breastfeeding | Eligible to start HAART |
Cd4 cutoff for initiation of HAART | ≤200 c/μl | ≤350 c/μl | ≤350 c/μl |